Archive

Sakeliga’s NHI Legal Battle for Constiutional Justice

Learn about Sakeliga’s NHI legal battle as they challenge the constitutionality of South Africa’s National Health Insurance plan.

Read More

Lenacapavir for HIV Prevention in South Africa

South Africa will introduce lenacapavir for HIV prevention in 2026, offering a new hope in the fight against HIV.

Read More

Sustainable Health Financing in Zimbabwe’s Strategy

Zimbabwe’s Health Minister emphasizes the importance of sustainable health financing for African nations amidst donor funding withdrawals.

Read More

Constitutional Court challenge to NHI Act by BHF

The Board of Healthcare Funders has initiated a Constitutional Court challenge to the NHI Act, citing issues in Parliament’s processes.

Read More

WHO Cuts Jobs and Restructures Operations

The World Health Organisation (WHO) is undertaking a major restructuring that includes over 1,000 job losses. It also involves relocating four key departments from its headquarters in Geneva. These changes are due to severe budget cuts following the United States’ decision to leave the agency.

Read More

Botswana’s Drug Supply Disrupted by Diamond Crisis

Botswana’s drug supply faces a crisis as President Boko declares a public health emergency and unveils a 5 billion pula plan.

Read More

GLP-1 Drugs Lower Cancer Rates in Weight Loss Study

Find out how GLP-1 drugs like Ozempic and Wegovy can lower cancer risk while aiding in weight loss and diabetes control.

Read More

BHF Challenges NHI Act Over Public Consultation Flaws

BHF challenges the NHI Act in court, claiming a flawed consultation process by Parliament makes the act invalid and unconstitutional.

Read More

Global Health Crisis and the Threat to NTD Programmes

Uncover the Global Health Crisis caused by the loss of crucial medicines, risking a resurgence of neglected tropical diseases.

Read More

Aspen Shares Nosedive 15% on JSE After Shock Profit Warning

Aspen Pharmacare shares see a sharp decline on the JSE following an alarming profit warning. What does it mean for investors?

Read More

Adcock Ingram Reports Flat Profit Despite Winter Surge

Adcock Ingram reports steady annual profits as winter demand for Panado and Corenza-C drives growth in the second half.

Read More

Pharma Giants Sidelined in R15.5bn HIV Drug Tender

The recent R15.5 billion ARV tender sidelines Pharma Giants in South Africa, raising questions about local production support.

Read More